The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab plus chemoradiotherapy (CRT) versus CRT or chemotherapy (CT) as the neoadjuvant treatment for patients (pts) with locally advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A multicenter, randomized controlled, open-label, phase IIb study (TERRIFIC).
 
Jia Wei
No Relationships to Disclose
 
Hongfeng Gou
No Relationships to Disclose
 
Ju Yang
No Relationships to Disclose
 
Xiaofeng Lu
No Relationships to Disclose
 
Ninggang Zhang
No Relationships to Disclose
 
Song Liu
No Relationships to Disclose
 
Qi Sun
No Relationships to Disclose
 
Hua Wang
No Relationships to Disclose
 
Meng Wang
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Liang Tao
No Relationships to Disclose
 
Song Liu
No Relationships to Disclose
 
Kun Yang
No Relationships to Disclose
 
Jiankun Hu
No Relationships to Disclose
 
Wenxian Guan
No Relationships to Disclose
 
Baorui Liu
No Relationships to Disclose